Bio-drugs are also referred as biomedicine, Western medicine, mainstream medicine, or conventional medicine. It is a branch of medical science that applies biological and physiological principles to clinical practice. Bio-drugs are based on standardized, evidence-based treatment validated through biological research, with the treatment administered through formally trained doctors, nurses, and other such licensed practitioners.
It includes many other biomedical disciplines and areas of specialty that contain the "bio" prefix such as molecular biology, biotechnology, biochemistry, embryology, cell biology, Nanobiotechnology, biological engineering, laboratory medical biology, genetics, cytogenetics, gene therapy, systems biology, bioinformatics, biostatistics, microbiology, anatomy, toxicology, neuroscience, parasitology, virology, immunology, pathology, physiology, and many that usually concern with life sciences as applied to medicine.
A biomolecule is also known as a biological molecule. It is a used term for molecules present in organisms that are essential to one or more typically biological processes, such as cell division, morphogenesis, or development. It also includes large macromolecules such as carbohydrates, proteins, lipids, and nucleic acids, as well as small molecules such as natural products primary metabolites, secondary metabolites.
The four major types of biomolecules are carbohydrates, lipids, nucleic acids, and proteins.
In other terms, Biotherapeutics are also called biologicals. Biotherapeutics are drug therapy products, where the active ingredient is extracted from a biological source. These products include recombinant proteins and hormones, growth factors, monoclonal antibodies cytokines, gene therapy products, gene-silencing/editing therapies, vaccines, cell-based products, tissue-engineered products, and stem cell therapies.
Title : Medical liver Biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/Tadalafil Combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia